Evidence map›Paper›PMID 35323227›Full record

ReviewJournal of functional biomaterials2022

Two-Dimensional Nanomaterials beyond Graphene for Biomedical Applications.

Maryam Derakhshi, Sahar Daemi, Pegah Shahini, Afagh Habibzadeh, Ebrahim Mostafavi, Ali Akbar Ashkarran

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Impact of Nanomedicine in Women's Metastatic Breast Cancer.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam DerakhshiPrecision Health Program and Department of Radiology, Michigan State University, East Lansing, MI 48824, USA.
Sahar DaemiDepartment of Chemistry, University of California Davis, One Shields Avenue, Davis, CA 95616, USA.ORCID 0000-0002-7969-3211
Pegah ShahiniPrecision Health Program and Department of Radiology, Michigan State University, East Lansing, MI 48824, USA.
Afagh HabibzadehDepartment of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
Ebrahim MostafaviStanford Cardiovascular Institute, Stanford, CA 94305, USA.ORCID 0000-0003-3958-5002
Ali Akbar AshkarranPrecision Health Program and Department of Radiology, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0001-7883-6690

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional (2D) nanomaterials (e.g., graphene) have shown to have a high potential in future biomedical applications due to their unique physicochemical properties such as unusual electrical conductivity, high biocompatibility, large surface area, and extraordinary thermal and mechanical properties. Although the potential of graphene as the most common 2D nanomaterials in biomedical applications has been extensively investigated, the practical use of other nanoengineered 2D materials beyond graphene such as transition metal dichalcogenides (TMDs), topological insulators (TIs), phosphorene, antimonene, bismuthene, metal-organic frameworks (MOFs) and MXenes for biomedical applications have not been appreciated so far. This review highlights not only the unique opportunities of 2D nanomaterials beyond graphene in various biomedical research areas such as bioelectronics, imaging, drug delivery, tissue engineering, and regenerative medicine but also addresses the risk factors and challenges ahead from the medical perspective and clinical translation of nanoengineered 2D materials. In conclusion, the perspectives and future roadmap of nanoengineered 2D materials beyond graphene are outlined for biomedical applications.

Indexed as

bioelectronicsdrug deliveryimagingregenerative medicinetissue engineeringtwo-dimensional nanomaterials

Identifiers

PMID35323227
PMCPMC8953174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.